Caricamento quotazioni...
Previsioni
Il prezzo obiettivo medio degli analisti è 219,07€ (+6,81%). La mediana è 223,20€ (+8,82%).
| Acquista |
25 |
| Mantieni |
10 |
| Vendi |
0 |
Notizie Vai al feed delle notizie
Welltower reports strong revenues, stock falls after missed FFO and profit-taking
Welltower beat expectations with revenue of $3.54 billion but missed adjusted FFO at $1.60 per share versus roughly $1.66 estimated. Management raised the full-year FFO guidance and increased the quarterly dividend by about 14.9% to $0.85 per share. After a strong premarket rally and amid a weaker overall market, profit-taking during the conference call led the stock to fall roughly 1.6% intraday. UBS reiterates a buy rating with a $271 price target, citing accelerated FFO and NOI growth in the senior housing segment. » Altro su de.investing.com
Welltower posts surge in revenue and hits record high after price-target increases
Welltower reported Q2 2026 revenue of $3.54 billion, comfortably beating the consensus estimate of $3.36 billion — a 39.1% increase year over year. Normalized FFO were $1.60 per diluted share, slightly below estimates of $1.66. Analysts subsequently raised price targets (Mizuho: $239 → $260; UBS previously at $271) and the stock rose 4.3% in after-hours trading to $258.95, surpassing its 52-week high. The senior housing portfolio remains the main growth driver, benefiting from an aging population and limited new supply. » Altro su de.investing.com
Welltower reaches record high of $250.14 after strong quarterly results
Welltower shares climbed to an all-time high of $250.14, 54.66% above the level 12 months ago. In Q1 2026 the company beat expectations with EPS of $1.02 versus $0.73 expected and revenue of $3.35 billion versus a $3.09 billion forecast. Welltower plans a bond issuance in Canada of about C$750 million with maturities of five to seven years. At the annual meeting all nine directors were re-elected, but the compensation of named executives was not approved; Mizuho and Barclays raised price targets or coverage. » Altro su de.investing.com
Dividendi storici Dividendi
Tutte le metriche sui dividendi Tutte le metricheDati finanziari dell'azienda
| (EUR) | giu 2026 | |
|---|---|---|
| Ricavi | 3,11Mld | 45,49% |
| Utile lordo | 1,22Mld | 43,81% |
| Utile netto | 210,55M | 17,80% |
| EBITDA | 1,16Mld | 44,61% |
Dati fondamentali
| Metrica | Valore |
|---|---|
Capitalizzazione di mercato | 149,89Mld€ |
Numero di azioni | 720,57M |
Massimo/minimo a 52 settimane | 219,08€ - 140,58€ |
Rendimento da dividendo | 1,27% |
Dividendi TTM | 2,64€ |
Beta | 0,76 |
Rapporto P/E | 125,55 |
Rapporto PEG | 16,05 |
Rapporto P/B | 3,68 |
Rapporto P/S | 13,84 |
Profilo aziendale
Welltower Inc. (NYSE:WELL), ein S&P 500-Unternehmen mit Hauptsitz in Toledo, Ohio, treibt den Wandel der Infrastruktur im Gesundheitswesen voran. Das Unternehmen investiert mit führenden Betreibern von Seniorenwohnungen, Anbietern von Post-Akut-Kliniken und Gesundheitssystemen, um die Immobilieninfrastruktur zu finanzieren, die für die Skalierung innovativer Versorgungsmodelle und die Verbesserung des Wohlbefindens der Menschen und der gesamten Gesundheitsversorgung erforderlich ist. Welltower™, ein Real Estate Investment Trust ("REIT"), besitzt Beteiligungen an Immobilien, die sich auf wichtige, wachstumsstarke Märkte in den Vereinigten Staaten, Kanada und Großbritannien konzentrieren und aus Seniorenwohnungen, postakuten Gemeinschaften und ambulanten medizinischen Einrichtungen bestehen.
| Nome | Welltower |
| CEO | Shankh S. Mitra |
| Sede centrale | Toledo,
oh Stati Uniti |
| Sito web | |
| Settore | Immobiliare |
| Industria | REITs sanitari |
| Quotazione in borsa | 19/03/1980 |
| Dipendenti | 712 |
Deep Dive
Simboli di borsa
| Borsa | Simbolo |
|---|---|
NYSE | WELL |
London Stock Exchange | 0LUS.L |
Frankfurt | HCW.F |
Düsseldorf | HCW.DU |
London | 0LUS.L |
SIX | HCW.SW |
München | HCW.MU |
Scopri gli asset
Gli azionisti di Welltower investono anche nei seguenti asset